Weak Q1, long-term optionality hinges on government policy

Delivered PAT is ₹523.6 Cr (10.4% margin), not ₹703 Cr; 34% discrepancy unexplained

OPM/EBITDA margin is 16.9% vs prior 13%, confirmed, though prior quarter comparison in transcript differs from YoY basis

WNA and ANS in trial; G3 HDAN utilization is ~4% of 1.27M ton capacity (vs prior 75-80% first-year guidance); Q1 volumes 3.29L tons G3 only

Confirmed; but margin decline expected as inventory gains reverse and price averaging occurs

Confirmed in Q&A; procurement well-timed to hedge subsidy delay

Policy approved; company still in preparatory phase, financial bids expected mid-October, no Board approval yet, no capex commitment

Prior Q4 FY26 call guided 75-80% first-year TAN utilization; Q1 FY27 actual is ~4% (3.29L tons G3 vs 1.27M ton capacity). Run rate 9.5-10K tons/qtr, nowhere near guidance. Ramp now tied to market recovery.

NUP 2026 approved in Q1, but financial bids not due until October, Board approval still pending, commissioning moved to 'within 2030' (vague, 4+ years). No acceleration visible despite policy support.

Segment EBIT up 67% to ₹239 Cr this quarter due to advance inventory purchase at ₹2,131 Cr revenue. Management now guides 'margins will decline as averaging of prices happen.' Signals Q2+ margin headwind.

Kharif subsidy announced ~10% higher but before geopolitical price spike; not yet revised upward. Industry pressed on interim relief; none granted. Chambal's early procurement hedges but sector margins under stress through Rabi.

Slight mixture of both. Will formally approach, process includes bank guarantees after government approval. Strong contender. Financial bids expected mid-October, Board approval prerequisite. Application window already open.

Not shown in segments—not booked yet in P&L, decapitalized as project cost. G1 96K tons, G2 1.85L tons, G3 3.29L tons. Maximum run rate 9.5–10K tons/qtr; cannot complete 1.27M tons before policy period ends.

Yes, advance NPK purchases from previous quarter helped placement and margins. Margins will decline as price averaging happens, but will maintain a certain level. Have tied up 8.5L tons with vendors.

Dilutive agreed, but scale benefits at single site (four plants together = largest in India, 2nd in Asia after Qatar QAFCO) offset it. Fixed costs, manpower, dealer cross-sell benefits large. Expected EBITDA ~₹12,000/ton steady-state (dollar conversion at ~₹13,500/USD today). Gains not capped if efficiencies driven.

Government watching stock levels, El Nino progress, Rabi readiness. Balancing act with fiscal situation. Urea and DAP costs fully absorbed, others supplementary. Possible interim relief sought but not yet granted. Expected action by October for Rabi.

Capacity and demand both rising. Infrastructure stress (roads, ports, blasting for coal/mining) is bullish. Will be short-to-slightly long ~1 year, then short again. Pricing structure and cost mix matter. Reliance entry hypothetical; can't speculate timeline. No roadblocks today.

Gas price Q1 was USD 17.25/NCV basis (provisional). Net borrowing ₹200 Cr (negative cash).

Yes, monsoon strengthened in July. Farmer urea sales 3.8L tons in July alone, NPK 92–93K tons. Pickup ~19–20K tons/day, quite good. Q2 expected to progress well; channel liquidation will create second round of demand.

Three factors: Gadepan-3 predominance this quarter (higher-margin plant), currency uptick (direct margin impact for G3), surplus ammonia sales at better margins.

Dividend: will maintain current levels (25% payout policy). Buyback: subject to lack of project visibility; if no major projects, will step in. Not on horizon now given capex pipeline.

Q1 FY27 volumes impacted by plant shutdown bunching; expected recovery in H2 as Kharif and Rabi seasons progress. Monsoon improvement in July signals better demand.

Q1 EBIT ₹239 Cr (13.7% margin) benefited from advance NPK purchase at lower prices. Price averaging will compress margins next quarter as subsidies remain delayed.

Assumes project cost optimization (₹9,000–10,000 Cr capex), dollar conversion at ~₹13,500/USD, efficiency gains not capped by policy. Highly dependent on capex execution and subsidy structure finalization.

Still in preparatory phase; Board approval not yet sought. Timing and amount subject to policy confirmation, vendor availability, and cost optimization. No capex commitment visible.

Kharif subsidy rates revised only +10%, announced before geopolitical price spike. Interim relief sought but not granted. Rabi subsidy not yet declared. Risk of demand destruction if subsidy remains below cost inflation.

TAN plant guided at 75–80% first-year utilization; Q1 actual is ~4% of 1.27M ton capacity. Ramp-up dependent on market demand recovery (mining, infrastructure, blasting). If demand doesn't materialize, high capex asset will drag ROI.

Transcript claims standalone PAT ₹703 Cr; delivered filed result shows ₹523.6 Cr—34% gap. Cause (consolidation, extraordinary items, one-time gains) not explained on call. Suggests either accounting opacity or extraordinary gains in claimed figure.

Q1 complex fertilizer EBIT jumped 67% to ₹239 Cr driven by advance inventory purchase at lower prices (non-recurring benefit). Management guides margins to decline as price averaging occurs and inventory cost basis rises. Risk of sharp Q2 margin contraction.

Fourth urea plant (~₹10,000 Cr capex) still in early preparatory phase. Financial bids not due until mid-October; Board approval required before commitment. ROE under NUP 2026 (12–16% floor-ceiling) is dilutive vs NIP 2012. Capex overrun, vendor delays, or policy changes could derail project economics.

Q1 FY27 saw delayed monsoon onset, below-normal rainfall, and delayed Kharif sowing (~23% lower YoY as of end-June). While monsoon recovered in July, sustained dry spell or crop failure could dampen demand.